Drug Type Small molecule drug |
Synonyms DRF 4832 |
Target |
Action agonists |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | Europe | - | - |
Lipid Metabolism Disorders | Preclinical | Europe | - | - |
Lipid Metabolism Disorders | Preclinical | - | - | |
Metabolic Syndrome | Preclinical | Europe | - | - |
Metabolic Syndrome | Preclinical | - | - |